Director/PDMR Shareholding

RNS Number : 7786M
GlaxoSmithKline PLC
11 May 2015
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Executive Director on 8 May 2015:

 


GSK Deferred Annual Bonus Plan

 

S Dingemans

 

 

 

Exercise of a nil priced option over 34,220 shares and 4,620 shares granted on 9 March 2012, both of which vested on 9 March 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 20,585.

 

The fair market value of an Ordinary Share at the point of exercise on 8 May 2015 was £14.72.

 

The Company and the above-mentioned Executive Director were advised of this transaction on 11 May 2015.

 

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

 

 

V A Whyte

Company Secretary

 

11 May 2015

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBFLFFEEFZBBL

Companies

GSK (GSK)
UK 100

Latest directors dealings